📌 AI Startups raise $250M+

DM on Twitter for anything

• Lightmatter raises a $155M Series C-2 for photonic chips

• VideoVerse raises a $45M PE round for AI videos

• Unnatural Products raises a $32M Series A for drug discovery

• ImpriMed raises a $23M Series A for AI oncology

• Unique raises a $6.4M Seed for FinanceGPT

• Upheal raises a $3.25M Seed for mental health notes

Not a sponsorship

Maximize SaaS Success 📢

Hi, I’m Talin.

I’ve worked in PE, early-stage SaaS & AI startups.

I help SaaS & AI startups unlock their potential with:

📈 Retention Cohorts

Master the art of SaaS unit economics and align your business and product seamlessly.

You will find out your product’s LTV, NRR, NDR, & more

👷🏻‍♂️ Innovate with Top Indian Talent: 70% Savings

Accelerate your growth without the hefty price tag.

I’ve placed remote roles across the spectrum: AI/ML, Marketing, Sales, Product, Customer Success, etc.

Top picks

A detailed highlight

Lightmatter

Amount: $155M 🎉

Valuation: $1.2B

Round: Series C-2

Lead Investor: Google Ventures, Viking Global Investors

Lightmatter is developing a full stack of photonic-enabled hardware and software solutions. These products are designed to change the way chips calculate and communicate, providing solutions for cloud providers, semiconductor companies, and enterprises. Their technology is essential for compute-intensive tasks like AI, offering increased speed, lower costs, and reduced environmental impact.

VideoVerse

Amount: $45M 🎉

Round: Private Equity Round

Lead Investor: Bluestone Equity Partners

VideoVerse offers a SaaS platform using AI for video editing. It transforms long videos into short-form content and highlights in real-time.

Unnatural Products

Amount: $32M 🎉

Round: Series A

Lead Investor: Artis Ventures (AV), Merck Global Health Innovation Fund

Unnatural Products is developing a technology platform that combines parallel experimentation and machine learning to create synthetic molecules for new drug development.

ImpriMed

Amount: $23M 🎉

Round: Series A

Lead Investor: Softbank Ventures Asia

ImpriMed's technology, initially focused on veterinary oncology, uses AI algorithms and live cancer cell analytics to predict individual responses to cancer treatments in dogs.

This approach personalizes therapy plans based on the specific cancer cell characteristics, aiming to enhance treatment precision and effectiveness. The technology's success in veterinary medicine is paving the way for its potential application in human oncology.

Unique

Amount: $6.4M 🎉

Round: Seed

Lead Investor: Vi Partners

They offer an AI-driven platform, Unique FinanceGPT, which provides solutions for automated client proposals, compliance information access, and personalized communication in the financial sector.

Upheal

Amount: $3.25M 🎉

Round: Seed

Lead Investor: N/a

Upheal is an AI-powered platform for mental health professionals, featuring therapist-focused video calling and automated AI-powered progress notes.

Other Rounds 🤏

Redrob raises a $4M Seed - AI-powered hiring & assessments

Arcanna.ai raises a $3.5M Seed - AI-assisted cybersecurity

Imaginario AI raises a $1M Seed - AI video search and curation

Peptris raises a $1M Pre-Seed - AI drug discovery

Bonus 🔥

For the most curious minds!